← Leaderboards
Elizabeth Selvin
Johns Hopkins University
$25,163,675
Attributed
$28,515,282
Total exposure
15
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.8M · FY2006–25$5M$3.8M$2.5M$1.3M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$28,515,282 · 15
By mechanism
R01$21,133,604 · 8
RF1$2,408,159 · 1
T32$2,274,589 · 1
K24$1,265,909 · 2
K01$606,308 · 1
N01$501,993 · 1
Top collaborators
- Christie M Ballantyne4 shared
- Lin Yee Chen4 shared
- Amil M Shah1 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Kerry J. Stewart$8,862,452
- Jennifer Ann Schrack$37,433,611
- Michal L Melamed$11,008,976
- Edgar Raymond Miller$10,285,998
- Ciprian M Crainiceanu$10,135,753
Others in their field
Top investigators on “Diabetes Mellitus”
- Jeffrey P Krischer · University Of South Florida$608,226,434
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$177,347,135
- John M Lachin · George Washington University$155,262,668
- David M Nathan · Massachusetts Institute Of Technology$142,806,023
- Judith S Hochman · New York University School Of Medicine$100,149,457
- Jose A Luchsinger · Columbia University Health Sciences$75,551,718
Research focus
Diabetes MellitusHyperglycemiaPersonsGlycosylated Hemoglobin AGlucoseCardiovascular DiseasesBiological MarkersRisk FactorsParticipantFundingCardiacAdultImpaired CognitionCardiovascular SystemVisitNon-Insulin-Dependent Diabetes MellitusGlycosylated Serum AlbuminMortalityFructosamineElderlyCommunitiesDesignCohortBlood Glucose Regulation
Grant awards (55)
Cardiovascular Epidemiology Institutional Training$832,504
T32 · FY2025 · HL · contact PI
Glucose patterns and clinical outcomes in the Dallas Heart Study: A pathway to precision diabetes$819,091
R01 · FY2025 · DK · contact PI
Glucose instability and neurocognitive outcomes in older adults$696,818
R01 · FY2025 · AG · contact PI
Glucose patterns and cardiac arrhythmias in older adults with diabetes$683,223
R01 · FY2025 · HL · contact PI
Effects of the DASH diet on glucose patterns in adults with type 2 diabetes$553,340
R01 · FY2025 · DK · contact PI
Glucose patterns and cardiac arrhythmias in older adults with diabetes$675,043
R01 · FY2024 · HL · contact PI
Clinical relevance of glucose patterns in older adults$643,920
R01 · FY2024 · DK · contact PI
Cardiovascular Epidemiology Institutional Training$589,601
T32 · FY2024 · HL · contact PI
Effects of the DASH diet on glucose patterns in adults with type 2 diabetes$563,399
R01 · FY2024 · DK · contact PI
THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY - FIELD CENTER - TASK AREA B$501,993
N01 · FY2024 · HL · contact PI
Research and Mentoring in the Clinical Epidemiology of Cardiovascular Disease and Type 2 Diabetes$122,431
K24 · FY2024 · HL · contact PI
Cardiovascular Epidemiology Institutional Training$852,484
T32 · FY2023 · HL · contact PI
Glucose patterns and cardiac arrhythmias in older adults with diabetes$701,062
R01 · FY2023 · HL · contact PI
Clinical relevance of glucose patterns in older adults$670,320
R01 · FY2023 · DK · contact PI
Effects of the DASH diet on glucose patterns in adults with type 2 diabetes$559,527
R01 · FY2023 · DK · contact PI
Research and Mentoring in the Clinical Epidemiology of Cardiovascular Disease and Type 2 Diabetes$122,431
K24 · FY2023 · HL · contact PI
Glucose patterns and cardiac arrhythmias in older adults with diabetes$767,658
R01 · FY2022 · HL · contact PI
Clinical relevance of glucose patterns in older adults$658,971
R01 · FY2022 · DK · contact PI
Effects of the DASH diet on glucose patterns in adults with type 2 diabetes$426,033
R01 · FY2022 · DK · contact PI
Research and Mentoring in the Clinical Epidemiology of Cardiovascular Disease and Type 2 Diabetes$122,431
K24 · FY2022 · HL · contact PI
Glucose instability and neurocognitive outcomes in older adults$2,408,159
RF1 · FY2021 · AG · contact PI
Clinical relevance of glucose patterns in older adults$757,378
R01 · FY2021 · DK · contact PI
Effects of the DASH diet on glucose patterns in adults with type 2 diabetes$479,876
R01 · FY2021 · DK · contact PI
Research and Mentoring in the Clinical Epidemiology of Cardiovascular Disease and Type 2 Diabetes$122,431
K24 · FY2021 · HL · contact PI
Diabetes and Prediabetes in Older Adults in ARIC$629,586
R01 · FY2020 · DK · contact PI
Research and Mentoring in the Clinical Epidemiology of Cardiovascular Disease and Type 2 Diabetes$122,431
K24 · FY2020 · HL · contact PI
Diabetes and Prediabetes in Older Adults in ARIC$646,769
R01 · FY2019 · DK · contact PI
Profiling Cardiovascular Events and Biomarkers in the Very Old to Improve Personalized Approaches for the Prevention of Cardiac and Vascular Disease$641,097
R01 · FY2019 · HL
Alternative Biomarkers of Hyperglycemia in ADVANCE$431,621
R01 · FY2019 · DK · contact PI
Research and Mentoring in the Clinical Epidemiology of Type 2 Diabetes$128,151
K24 · FY2019 · DK · contact PI
Profiling Cardiovascular Events and Biomarkers in the Very Old to Improve Personalized Approaches for the Prevention of Cardiac and Vascular Disease$791,271
R01 · FY2018 · HL
Diabetes and Prediabetes in Older Adults in ARIC$658,494
R01 · FY2018 · DK · contact PI
Alternative Biomarkers of Hyperglycemia in ADVANCE$444,389
R01 · FY2018 · DK · contact PI
Research and Mentoring in the Clinical Epidemiology of Type 2 Diabetes$131,228
K24 · FY2018 · DK · contact PI
Profiling Cardiovascular Events and Biomarkers in the Very Old to Improve Personalized Approaches for the Prevention of Cardiac and Vascular Disease$794,225
R01 · FY2017 · HL
Diabetes and Prediabetes in Older Adults in ARIC$672,056
R01 · FY2017 · DK · contact PI
Alternative Biomarkers of Hyperglycemia in ADVANCE$591,924
R01 · FY2017 · DK · contact PI
Research and Mentoring in the Clinical Epidemiology of Type 2 Diabetes$131,414
K24 · FY2017 · DK · contact PI
Profiling Cardiovascular Events and Biomarkers in the Very Old to Improve Personalized Approaches for the Prevention of Cardiac and Vascular Disease$830,544
R01 · FY2016 · HL
Diabetes and Prediabetes in Older Adults in ARIC$778,648
R01 · FY2016 · DK · contact PI
Alternative Biomarkers of Hyperglycemia in ADVANCE$578,247
R01 · FY2016 · DK · contact PI
Research and Mentoring in the Clinical Epidemiology of Type 2 Diabetes$131,184
K24 · FY2016 · DK · contact PI
Comparative Epidemiology for Emerging Glycemic Markers$624,548
R01 · FY2015 · DK · contact PI
Research and Mentoring in the Clinical Epidemiology of Type 2 Diabetes$131,777
K24 · FY2015 · DK · contact PI
Comparative Epidemiology for Emerging Glycemic Markers$591,068
R01 · FY2014 · DK · contact PI
Comparative Epidemiology for Emerging Glycemic Markers$526,890
R01 · FY2013 · DK · contact PI
Comparative Epidemiology for Emerging Glycemic Markers$568,059
R01 · FY2012 · DK · contact PI
Comparative Epidemiology for Emerging Glycemic Markers$678,509
R01 · FY2011 · DK · contact PI
Glycemia Advanced Gylcation End products (AGEs) and Atherosclerosis in Diabetes$117,482
K01 · FY2010 · DK · contact PI
Glycemia Advanced Gylcation End products (AGEs) and Atherosclerosis in Diabetes$117,897
K01 · FY2009 · DK · contact PI
Defining the Clinical Significance of HbA1c Prior to the Onset of Diabetes$160,720
R21 · FY2008 · DK · contact PI
Glycemia Advanced Gylcation End products (AGEs) and Atherosclerosis in Diabetes$118,865
K01 · FY2008 · DK · contact PI
Defining the Clinical Significance of HbA1c Prior to the Onset of Diabetes$164,000
R21 · FY2007 · DK · contact PI
Glycemia Advanced Gylcation End products (AGEs) and Atherosclerosis in Diabetes$127,497
K01 · FY2007 · DK · contact PI
Glycemia Advanced Gylcation End products (AGEs) and Atherosclerosis in Diabetes$124,567
K01 · FY2006 · DK · contact PI